Previous 10 | Next 10 |
BOTHELL, Wash. , Oct. 31, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, ("BioLife" or the "Company"), today announced that the Company's third quarter 2019 financial re...
On July 5 this year, we noted a huge valuation gap between two (roughly) similar bio-preservation media and delivery companies which we found difficult to explain. The (relatively) cheap company here is BioLife ( BLFS ), a stock we hold in the SHU portfolio since last year. The other sto...
BOTHELL, Wash. , Oct. 14, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced three new patents for inventions related to cryopreservation, thawing and cold ch...
Cryoport is a Commodity Business Trading at 10x Revenue, There is No Regulatory Moat Cryoport, Inc. ( CYRX ) provides cryogenic shipping and logistics services to the life sciences industry. Specifically the company is hyped as the primary, and in some cases sole, provider of shipment logi...
BOTHELL, Wash. , Sept. 24, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced a co-investment accelerator program with Casdin Capital, targeting e...
BOSTON, Sept. 24, 2019 (GLOBE NEWSWIRE) -- iVexSol , a newly formed viral vector manufacturing company, today announced $2.0 million in new convertible debt funding led by Casdin Capital, LLC and BioLife Solutions (NASDAQ:BLFS) . The company is founded on a next generation manuf...
BOTHELL, Wash. , Sept. 16, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) , a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers have adopted the evo cold chain manage...
BOTHELL, Wash. , Sept. 3, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced that Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage b...
BOTHELL, Wash. , Aug. 28, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the hiring of two key sales executives who will assist in b...
Company Overview and History According to its filings , Cryoport ( CYRX ) “became public by a reverse merger with a ‘shell’ company in May 2005.” From the beginning, the company specialized in developing equipment for transporting biological materials at cryogeni...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...